Status:

COMPLETED

Effect of Smoking Cessation on Tuberculosis Treatment Outcomes

Lead Sponsor:

Dow University of Health Sciences

Conditions:

Tuberculosis, Pulmonary

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study was a Randomized Controlled Trial conducted at Ojha Institute of Chest Diseases, Dow University of Health Sciences, Karachi, among pulmonary tuberculosis patients

Eligibility Criteria

Inclusion

  • pulmonary tuberculosis patients of age 18 years or above
  • registered under Directly Observed Treatment Short course (DOTS) at Ojha Institute of Chest Diseases
  • reported to have smoked 100 plus cigarettes in past and currently smoking cigarettes

Exclusion

  • Extra pulmonary tuberculosis
  • drug resistant tuberculosis
  • pregnancy
  • positive history of epilepsy

Key Trial Info

Start Date :

November 6 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 15 2019

Estimated Enrollment :

292 Patients enrolled

Trial Details

Trial ID

NCT04848246

Start Date

November 6 2017

End Date

October 15 2019

Last Update

April 19 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dow University of Health Sciences

Karachi, Sindh, Pakistan